Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
acetaminophen + hydrocodone ER
- Development stage
- Unknown
- Lead developer
- Humanwell Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Acetaminophen + hydrocodone ER is an oral extended-release combination analgesic developed by Wuhan Humanwell Hi-Tech Industry for the management of moderate to severe pain. This product combines hydrocodone bitartrate, a semi-synthetic opioid agonist that primarily targets mu-opioid receptors to alter the perception of and response to pain, with acetaminophen, a non-opioid analgesic and antipyretic that likely acts through the inhibition of prostaglandin synthesis in the central nervous system. The extended-release formulation is designed to provide sustained pain relief, potentially improving patient compliance and reducing the frequency of dosing compared to immediate-release formulations. As of the latest reports, the drug has reached the NDA filing stage in China.
- Other names
- 氨酚氢可酮缓释片acetaminophen and hydrocodone bitartrate extended-release tablets
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)
Beyond the preview
Go deeper on acetaminophen + hydrocodone ER.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on acetaminophen + hydrocodone ER.